Known 0 5 0 5 O
intolerance 6 17 6 17 O
or 18 20 18 20 O
allergy 21 28 21 28 O
to 29 31 29 31 O
MR 32 34 32 34 B-allergy_name
contrast 35 43 35 43 I-allergy_name
agent 44 49 44 49 I-allergy_name
( 50 51 50 51 I-allergy_name
gadolinium 51 61 51 61 I-allergy_name
chelates 62 70 62 70 I-allergy_name
) 70 71 70 71 I-allergy_name

Men 0 3 72 75 B-gender

No 0 2 76 78 O
prior 3 8 79 84 B-treatment
interventional 9 23 85 99 I-treatment
therapy 24 31 100 107 I-treatment
for 32 35 108 111 O
the 36 39 112 115 O
osteoid 40 47 116 123 B-cancer
osteoma 48 55 124 131 I-cancer

Patients 0 8 132 140 O
must 9 13 141 145 O
have 14 18 146 150 O
medically 19 28 151 160 O
uncontrolled 29 41 161 173 O
pain 42 46 174 178 O
from 47 51 179 183 O
an 52 54 184 186 O
osteoid 55 62 187 194 B-cancer
osteoma 63 70 195 202 I-cancer
, 70 71 202 203 O
as 72 74 204 206 O
defined 75 82 207 214 O
by 83 85 215 217 O
pain 86 90 218 222 O
, 90 91 222 223 O
which 92 97 224 229 O
, 97 98 229 230 O
in 99 101 231 233 O
the 102 105 234 237 O
view 106 110 238 242 O
of 111 113 243 245 O
the 114 117 246 249 O
referring 118 127 250 259 O
orthopedic 128 138 260 270 O
oncologist 139 149 271 281 O
significantly 150 163 282 295 O
interferes 164 174 296 306 O
with 175 179 307 311 O
that 180 184 312 316 O
patient 185 192 317 324 O
's 192 194 324 326 O
activities 195 205 327 337 O
of 206 208 338 340 O
daily 209 214 341 346 O
living 215 221 347 353 O

Patients 0 8 354 362 O
with 9 13 363 367 O
an 14 16 368 370 O
active 17 23 371 377 B-chronic_disease
infection 24 33 378 387 I-chronic_disease
or 34 36 388 390 O
severe 37 43 391 397 O
hematological 44 57 398 411 B-chronic_disease
, 57 58 411 412 O
neurological 59 71 413 425 B-chronic_disease
, 71 72 425 426 O
or 73 75 427 429 O
other 76 81 430 435 O
uncontrolled 82 94 436 448 B-chronic_disease
disease 95 102 449 456 I-chronic_disease

Patients 0 8 457 465 O
with 9 13 466 470 O
an 14 16 471 473 O
acute 17 22 474 479 O
medical 23 30 480 487 O
condition 31 40 488 497 O
( 41 42 498 499 O
e.g. 42 46 499 503 O
pneumonia 47 56 504 513 B-chronic_disease
, 56 57 513 514 O
sepsis 58 64 515 521 B-chronic_disease
) 64 65 521 522 O
that 66 70 523 527 O
is 71 73 528 530 O
expected 74 82 531 539 O
to 83 85 540 542 O
hinder 86 92 543 549 O
them 93 97 550 554 O
from 98 102 555 559 O
completing 103 113 560 570 O
this 114 118 571 575 O
study 119 124 576 581 O

Pregnancy 0 9 582 591 B-pregnancy

Severe 0 6 592 598 B-chronic_disease
hypertension 7 19 599 611 I-chronic_disease
( 20 21 612 613 O
diastolic 21 30 613 622 B-clinical_variable
BP 31 33 623 625 I-clinical_variable
> 34 35 626 627 O
100 36 39 628 631 B-lower_bound
on 40 42 632 634 O
medication 43 53 635 645 O
) 53 54 645 646 O

Targeted 0 8 647 655 O
bone 9 13 656 660 B-cancer
/ 13 14 660 661 I-cancer
tumor 14 19 661 666 I-cancer
interface 20 29 667 676 O
is 30 32 677 679 O
accessible 33 43 680 690 O
to 44 46 691 693 O
the 47 50 694 697 O
ExAblate 51 59 698 706 O
device 60 66 707 713 O
and 67 70 714 717 O
located 71 78 718 725 O
in 79 81 726 728 O
a 82 83 729 730 O
rib 84 87 731 734 O
, 87 88 734 735 O
extremity 89 98 736 745 O
( 99 100 746 747 O
excluding 100 109 747 756 O
intra 110 115 757 762 O
- 115 116 762 763 O
articular 116 125 763 772 O
location 126 134 773 781 O
) 134 135 781 782 O
, 135 136 782 783 O
pelvis 137 143 784 790 O
, 143 144 790 791 O
shoulders 145 154 792 801 O
( 155 156 802 803 O
including 156 165 803 812 O
clavicles 166 175 813 822 O
) 175 176 822 823 O
, 176 177 823 824 O
or 178 180 825 827 O
the 181 184 828 831 O
sternum 185 192 832 839 O

Targeted 0 8 840 848 O
tumor 9 14 849 854 B-cancer
in 15 17 855 857 O
the 18 21 858 861 O
skull 22 27 862 867 O
/ 27 28 867 868 O
spine 28 33 868 873 O

Targeted 0 8 874 882 O
tumor 9 14 883 888 B-cancer
is 15 17 889 891 O
< 18 19 892 893 O
1 20 21 894 895 B-upper_bound
cm 22 24 896 898 I-upper_bound
from 25 29 899 903 O
a 30 31 904 905 O
major 32 37 906 911 O
nerve 38 43 912 917 O

ages 0 4 918 922 B-age
â‰¥ 5 6 923 924 O
10 7 9 925 927 B-lower_bound
years 10 15 928 933 I-lower_bound
old 16 19 934 937 I-lower_bound

women 0 5 938 943 B-gender

